Axial Spondyloarthritis, Cardiac Disease, Heart Failure, Heart Failure, Diastolic, Heart Failure, Systolic, Inflammatory Arthritis, Ischemic Heart Disease, Left Ventricular Systolic Dysfunction, Myocardial Dysfunction, Myocardial Infarction, Rheumatoid Arthritis, Spondylitis, Ankylosing, Spondyloarthritis, Stroke, Valvular Heart Disease
Conditions
Brief summary
The goal of this prospective cohort study is to investigate cardiac comorbidity in a random sample of approximately 1200 patients from a population of outpatients with rheumatoid arthritis and axial spondyloarthritis referred to collectively as inflammatory arthritis (IA). The main questions it aims to answer are: * Using conventional echocardiography, the investigators aim to determine the prevalence of overt and asymptomatic cardiac dysfunction in a large random sample of outpatients with IA. Cardiac dysfunction will be evaluated by echocardiography and cardiac biomarkers (NT-pro-BNP, hs-TNT and hs-CRP). * In patients without known heart disease: Using 2, 5 and 10 year follow-up, the investigators aim to examine if advanced echocardiography can be used to detect early signs of heart disease by investigating the clinical significance of adding deformation measures - alone and in combination with selected biomarkers - to conventional risk factors in the cardiac risk assessment of patients with IA Participants will undergo an echocardiographic examination in combination with a general health assessment including obtainment of cardiac biomarkers and a electrocardiogram. Using advanced echocardiography - Tissue Doppler Imaging, 2- dimensional speckle tracking echocardiography, 3D-echocardiography and 3-dimensional speckle tracking echocardiography - the investigators also aim to compare myocardial deformation parameters of patients with IA to a gender and age matched control group without IA from the Copenhagen City Heart Study.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Persons with a diagnosis of with a confirmed diagnosis of rheumatoid Arthritis or axial spondyloarthritis
Exclusion criteria
* Persons not able to cooperate * Persons unable understand and sign informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Cardiovascular mortality | 2-year follow-up | — |
| Admission with congestive heart failure | 2-year follow-up | — |
| Myocardial infarction | 2-year follow-up | — |
| Revascularization | 2-year follow-up | Percutaneous coronary intervention or coronary artery bypass graft |
| Incident Heart Failure | 2-year follow-up | — |
| Incident valvular disease | 2-year follow-up | — |
Countries
Denmark